ビペリデン市場：投与量別、用途別-2024-2030年の世界予測

ビペリデン市場規模は2023年に3億6,427万米ドルと推定され、2024年には3億8,470万米ドルに達すると予測され、CAGR 5.69%で2030年には5億3,676万米ドルに達する見込みです。

ビペリデンは抗コリン薬に分類される医薬化合物で、主に鎮痙作用と抗パーキンソン病作用で利用されています。中枢と末梢神経系のアセチルコリン受容体を遮断することにより作用します。この作用により、硬直、振戦、唾液分泌過多などのパーキンソン病に関連する症状の軽減に役立ちます。さらに、ビペリデンは、不随意筋運動などの抗精神病薬の副作用に対抗するために使用されます。経口剤や注射剤などさまざまな剤形があるため、患者のニーズに合わせて柔軟に投与することができます。すべての薬と同様に、ビペリデンの使用は、潜在的な副作用に対する治療効果のバランスをとるために、医療専門家の指導のもとで厳重に管理されなければならないです。世界のパーキンソン病患者数の増加が、ビペリデンの需要を牽引しています。高齢者層はパーキンソン病にかかりやすいため、高齢者層の拡大がビペリデンのニーズの増加を促進しています。さらに、ビペリデンの有効性を向上させ、副作用を軽減するための継続的な研究が、市場の成長に寄与しています。しかし、ビペリデンには口渇、かすみ目、便秘などの抗コリン作用の副作用があるため、患者によっては使用が制限される可能性があります。とはいえ、送達メカニズムを改善し、副作用を軽減し、患者のコンプライアンスを向上させたビペリデン製剤の開発は、大きな機会をもたらします。医療支出が増加し、未開拓の患者層が存在する新興市場への進出は、大きな成長の可能性を秘めています。

投与使いやすさと患者のコンプライアンスにより経口投与への嗜好が高まる

ビペリデンの注射剤は、主に経口投与が不可能な急性症状における迅速な症状コントロールに使用されます。注射剤は血漿中濃度が速やかにピークに達するため、急性のジストニー反応を管理するための効率的な方法です。この投与経路では、抗コリン性副作用などの潜在的なリスクを軽減するために、医療専門家による綿密な投与とモニタリングが必要となります。ビペリデンの経口投与は、その使いやすさと患者のコンプライアンスにより、長期管理に広く利用されています。錠剤で入手可能なため、薬剤を持続的に放出することができ、一日中安定した血漿中濃度を保つことができます。この方法は慢性的な症状を管理するのに適しており、患者は最小限の混乱で規則正しい日常生活を維持することができます。

応用例強力な抗コリン剤としての薬剤誘発性運動障害におけるビペリデンの増殖

ビペリデンは強力な抗コリン薬であり、薬剤誘発性運動障害（DIMD）の管理に頻繁に使用されます。DIMDはしばしば抗精神病薬の副作用であり、抗精神病薬は主に様々な精神疾患の治療に使用されます。これらの運動障害はジストニア、アカシジア、パーキンソニズム、遅発性ジスキネジアとして現れます。ビペリデンはアセチルコリン受容体を遮断することにより、抗精神病薬によって引き起こされる脳内の神経伝達物質の不均衡を是正します。筋強剛、振戦、不随意筋運動などの症状を緩和し、DIMDに苦しむ患者のQOLを著しく改善します。パーキンソン病は中枢神経系の変性疾患で、運動系に影響を及ぼします。アセチルコリンの作用に拮抗することにより、ビペリデンは脳内のドーパミンとアセチルコリンのバランスを回復させます。この調整により、パーキンソン病に伴う運動症状の緩和を助けますが、病気の進行を元に戻したり、非運動症状に影響を与えることはありません。トゥレット症候群は神経疾患の一種であり、チックと呼ばれる反復的、定型的な不随意運動や発声を示します。トゥレット症候群に対する有効性は、個々の患者の薬に対する反応と症状の性質に大きく依存します。ビペリデンの抗コリン作用は、特定の運動性チックを緩和するのに役立つが、臨床医はその利点と潜在的な副作用を慎重に比較検討する必要があります。

地域的洞察

南北アメリカのビペリデン市場は、強固な医療インフラ、神経疾患に対する高い認識、強力な規制当局のサポートが特徴です。米国は同地域最大の市場であり、高齢化とパーキンソン病と錐体外路症状の蔓延により大きな需要があります。規制当局の承認と保険適用方針が、この地域の市場力学に大きな影響を与えています。さらに、ラテンアメリカは、医療施設の改善、医療費の増加、神経疾患に対する意識の高まりから、有望な成長ポテンシャルを示しています。欧州、中東、アフリカ地域では、欧州がビペリデンの中心的な市場として際立っており、先進的な医療システム、高額な医療費、パーキンソン病罹患率の増加などがその背景にあります。老舗製薬企業の存在と良好な規制環境が市場をさらに牽引しています。アジア太平洋は、人口の急増、医療ニーズの高まり、パーキンソン病やその他の関連疾患の有病率の増加によって、市場情勢が好機を迎えています。中国やインドを含む国々は、その膨大な人口基盤と急速に発展する医療部門により、極めて重要な位置を占めています。医療インフラへの投資の増加、中間層の人口増加、神経疾患に対する意識の高まりが、この地域の市場を推進する主要要因となっています。

FPNVポジショニングマトリックス

FPNVポジショニングマトリックスはビペリデン市場の評価において極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を記載しています。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます。フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、ビペリデン市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、このセグメントの競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています。

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を記載しています。

4.競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力について徹底的な評価を行います。

5.製品開発とイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を記載しています。

本レポートは、以下のような主要な質問に対応しています。

1.ビペリデン市場の市場規模と予測は？

2.ビペリデン市場の予測期間中に投資を検討すべき製品、セグメント、用途、セグメントは何か？

3.ビペリデン市場の技術動向と規制枠組みは？

4.ビペリデン市場における主要ベンダーの市場シェアは？

5.ビペリデン市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • パーキンソン病の治療におけるビペリデンの使用が世界中で増加
    • 薬剤誘発性運動障害の医薬品開発におけるビペリデンの使用増加
  • 抑制要因
    • ビペリデン製造の認知度が低く、コストが高い
  • 機会
    • ビペリデン系薬剤の適用性を高めるための継続的な研究開発
    • 製薬会社によるビペリデン生産への新たな投資
  • 課題
    • ビペリデンに関連する潜在的な健康への影響
• 市場セグメンテーション分析
  • 投与量：使いやすさと患者のコンプライアンスのため、経口投与が好まれる傾向が高まっている
  • 用途：薬剤誘発性運動障害における強力な抗コリン剤としてのビペリデンの増殖
• 市場ディスラプション分析
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 価格分析
• 技術分析
• 特許分析
• 貿易分析
• 規制枠組みの分析

第6章 ビペリデン市場管理別

• イントロダクション
• 注射
• 経口

第7章 ビペリデン市場：用途別

• イントロダクション
• 薬剤誘発性運動障害
• パーキンソン病
• トゥレット症候群

第8章 南北アメリカのビペリデン市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋のビペリデン市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカのビペリデン市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
• 戦略分析と提言

第12章 競合ポートフォリオ

• 主要企業プロファイル
• 主要製品ポートフォリオ

LIST OF FIGURES

• FIGURE 1. BIPERIDEN MARKET RESEARCH PROCESS
• FIGURE 2. BIPERIDEN MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL BIPERIDEN MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL BIPERIDEN MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. GLOBAL BIPERIDEN MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. BIPERIDEN MARKET DYNAMICS
• FIGURE 7. GLOBAL BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2023 VS 2030 (%)
• FIGURE 8. GLOBAL BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL BIPERIDEN MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 10. GLOBAL BIPERIDEN MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. AMERICAS BIPERIDEN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 12. AMERICAS BIPERIDEN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. UNITED STATES BIPERIDEN MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 14. UNITED STATES BIPERIDEN MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. ASIA-PACIFIC BIPERIDEN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 16. ASIA-PACIFIC BIPERIDEN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BIPERIDEN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BIPERIDEN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. BIPERIDEN MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 20. BIPERIDEN MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. BIPERIDEN MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL BIPERIDEN MARKET SIZE, 2018-2023 (USD MILLION)
• TABLE 4. GLOBAL BIPERIDEN MARKET SIZE, 2024-2030 (USD MILLION)
• TABLE 5. GLOBAL BIPERIDEN MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 6. GLOBAL BIPERIDEN MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 7. GLOBAL BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 8. GLOBAL BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 9. GLOBAL BIPERIDEN MARKET SIZE, BY INJECTION, BY REGION, 2018-2023 (USD MILLION)
• TABLE 10. GLOBAL BIPERIDEN MARKET SIZE, BY INJECTION, BY REGION, 2024-2030 (USD MILLION)
• TABLE 11. GLOBAL BIPERIDEN MARKET SIZE, BY ORAL, BY REGION, 2018-2023 (USD MILLION)
• TABLE 12. GLOBAL BIPERIDEN MARKET SIZE, BY ORAL, BY REGION, 2024-2030 (USD MILLION)
• TABLE 13. GLOBAL BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 14. GLOBAL BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 15. GLOBAL BIPERIDEN MARKET SIZE, BY DRUG-INDUCED MOVEMENT DISORDERS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 16. GLOBAL BIPERIDEN MARKET SIZE, BY DRUG-INDUCED MOVEMENT DISORDERS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 17. GLOBAL BIPERIDEN MARKET SIZE, BY PARKINSON DISEASE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 18. GLOBAL BIPERIDEN MARKET SIZE, BY PARKINSON DISEASE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 19. GLOBAL BIPERIDEN MARKET SIZE, BY TOURET SYNDROME, BY REGION, 2018-2023 (USD MILLION)
• TABLE 20. GLOBAL BIPERIDEN MARKET SIZE, BY TOURET SYNDROME, BY REGION, 2024-2030 (USD MILLION)
• TABLE 21. AMERICAS BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 22. AMERICAS BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 23. AMERICAS BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 24. AMERICAS BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 25. AMERICAS BIPERIDEN MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 26. AMERICAS BIPERIDEN MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 27. ARGENTINA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 28. ARGENTINA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 29. ARGENTINA BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 30. ARGENTINA BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 31. BRAZIL BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 32. BRAZIL BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 33. BRAZIL BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 34. BRAZIL BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 35. CANADA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 36. CANADA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 37. CANADA BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 38. CANADA BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 39. MEXICO BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 40. MEXICO BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 41. MEXICO BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 42. MEXICO BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 43. UNITED STATES BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 44. UNITED STATES BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 45. UNITED STATES BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 46. UNITED STATES BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 47. UNITED STATES BIPERIDEN MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
• TABLE 48. UNITED STATES BIPERIDEN MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
• TABLE 49. ASIA-PACIFIC BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 50. ASIA-PACIFIC BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 51. ASIA-PACIFIC BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 52. ASIA-PACIFIC BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 53. ASIA-PACIFIC BIPERIDEN MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 54. ASIA-PACIFIC BIPERIDEN MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 55. AUSTRALIA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 56. AUSTRALIA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 57. AUSTRALIA BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 58. AUSTRALIA BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 59. CHINA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 60. CHINA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 61. CHINA BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 62. CHINA BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 63. INDIA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 64. INDIA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 65. INDIA BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 66. INDIA BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 67. INDONESIA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 68. INDONESIA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 69. INDONESIA BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 70. INDONESIA BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 71. JAPAN BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 72. JAPAN BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 73. JAPAN BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 74. JAPAN BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 75. MALAYSIA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 76. MALAYSIA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 77. MALAYSIA BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 78. MALAYSIA BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 79. PHILIPPINES BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 80. PHILIPPINES BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 81. PHILIPPINES BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 82. PHILIPPINES BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 83. SINGAPORE BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 84. SINGAPORE BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 85. SINGAPORE BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 86. SINGAPORE BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 87. SOUTH KOREA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 88. SOUTH KOREA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 89. SOUTH KOREA BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 90. SOUTH KOREA BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 91. TAIWAN BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 92. TAIWAN BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 93. TAIWAN BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 94. TAIWAN BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 95. THAILAND BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 96. THAILAND BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 97. THAILAND BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 98. THAILAND BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 99. VIETNAM BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 100. VIETNAM BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 101. VIETNAM BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 102. VIETNAM BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 103. EUROPE, MIDDLE EAST & AFRICA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 104. EUROPE, MIDDLE EAST & AFRICA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 105. EUROPE, MIDDLE EAST & AFRICA BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 106. EUROPE, MIDDLE EAST & AFRICA BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 107. EUROPE, MIDDLE EAST & AFRICA BIPERIDEN MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 108. EUROPE, MIDDLE EAST & AFRICA BIPERIDEN MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 109. DENMARK BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 110. DENMARK BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 111. DENMARK BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 112. DENMARK BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 113. EGYPT BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 114. EGYPT BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 115. EGYPT BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 116. EGYPT BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 117. FINLAND BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 118. FINLAND BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 119. FINLAND BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 120. FINLAND BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 121. FRANCE BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 122. FRANCE BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 123. FRANCE BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 124. FRANCE BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 125. GERMANY BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 126. GERMANY BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 127. GERMANY BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 128. GERMANY BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 129. ISRAEL BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 130. ISRAEL BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 131. ISRAEL BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 132. ISRAEL BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 133. ITALY BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 134. ITALY BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 135. ITALY BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 136. ITALY BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 137. NETHERLANDS BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 138. NETHERLANDS BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 139. NETHERLANDS BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 140. NETHERLANDS BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 141. NIGERIA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 142. NIGERIA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 143. NIGERIA BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 144. NIGERIA BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 145. NORWAY BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 146. NORWAY BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 147. NORWAY BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 148. NORWAY BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 149. POLAND BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 150. POLAND BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 151. POLAND BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 152. POLAND BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 153. QATAR BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 154. QATAR BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 155. QATAR BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 156. QATAR BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 157. RUSSIA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 158. RUSSIA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 159. RUSSIA BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 160. RUSSIA BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 161. SAUDI ARABIA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 162. SAUDI ARABIA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 163. SAUDI ARABIA BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 164. SAUDI ARABIA BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 165. SOUTH AFRICA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 166. SOUTH AFRICA BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 167. SOUTH AFRICA BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 168. SOUTH AFRICA BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 169. SPAIN BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 170. SPAIN BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 171. SPAIN BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 172. SPAIN BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 173. SWEDEN BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 174. SWEDEN BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 175. SWEDEN BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 176. SWEDEN BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 177. SWITZERLAND BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 178. SWITZERLAND BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 179. SWITZERLAND BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 180. SWITZERLAND BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 181. TURKEY BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 182. TURKEY BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 183. TURKEY BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 184. TURKEY BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 185. UNITED ARAB EMIRATES BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 186. UNITED ARAB EMIRATES BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 187. UNITED ARAB EMIRATES BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 188. UNITED ARAB EMIRATES BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 189. UNITED KINGDOM BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2018-2023 (USD MILLION)
• TABLE 190. UNITED KINGDOM BIPERIDEN MARKET SIZE, BY ADMINISTRATION, 2024-2030 (USD MILLION)
• TABLE 191. UNITED KINGDOM BIPERIDEN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 192. UNITED KINGDOM BIPERIDEN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 193. BIPERIDEN MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 194. BIPERIDEN MARKET, FPNV POSITIONING MATRIX, 2023

[197 Pages Report] The Biperiden Market size was estimated at USD 364.27 million in 2023 and expected to reach USD 384.70 million in 2024, at a CAGR 5.69% to reach USD 536.76 million by 2030.

Biperiden is a pharmaceutical compound classified as an anticholinergic agent, primarily utilized for its antispasmodic and antiparkinsonian properties. It operates by blocking acetylcholine receptors in the central and peripheral nervous system. This action helps in reducing the symptoms associated with Parkinson's disease, such as rigidity, tremors, and excessive salivation. Additionally, biperiden is employed to counteract the side effects of antipsychotic medications, including involuntary muscle movements. Its availability in various forms, including oral and injectable, allows for flexibility in administration based on patient needs. As with all medications, the use of biperiden must be closely managed under the guidance of a healthcare professional to balance therapeutic benefits against potential side effects. The increasing number of Parkinson's disease cases globally drives the demand for Biperiden. As older age groups are more prone to Parkinson's, the expanding elderly demographic fosters an Increasing need for biperiden. Moreover, Continuous research on improving Biperiden's efficacy and reducing side effects contributes to market growth. However, biperiden's anticholinergic side effects, such as dry mouth, blurred vision, and constipation, may limit its usability for some patients. Nevertheless, the development of biperiden formulations with improved delivery mechanisms, reduced side effects, and enhanced patient compliance presents significant opportunities. Expanding into emerging markets with increasing healthcare expenditure and untapped patient demographics offers considerable growth potential.

Administration: Increasing preferences for Oral administration owing to their ease of use and patient compliance

The injectable form of Biperiden is primarily used for rapid symptom control in acute episodes where oral administration is not feasible. The injectable route provides quick plasma concentration peaks, making it an efficient method for managing acute dystonic reactions. This administration route demands meticulous dosing and monitoring by healthcare professionals to mitigate potential risks such as anticholinergic side effects. Oral administration of Biperiden is widely utilized for long-term management due to its ease of use and patient compliance. Available in tablet form, it allows for a sustained release of the medication, facilitating stable plasma concentrations throughout the day. This method is preferable for managing chronic symptoms, allowing patients to maintain regular daily activities with minimal disruption.

Application: Proliferation of biperiden in drug-induced movement disorders as potent anticholinergic agent

Biperiden is a potent anticholinergic agent that is frequently used in the management of drug-induced movement disorders (DIMDs). DIMDs are often a side effect of antipsychotic medications, which are primarily used to treat various psychiatric disorders. These movement disorders can manifest as dystonia, akathisia, parkinsonism, and tardive dyskinesia. Biperiden works by blocking acetylcholine receptors, thereby correcting the imbalance of neurotransmitters in the brain caused by antipsychotic medications. It serves to alleviate symptoms such as muscle stiffness, tremors, and involuntary muscle movements, significantly improves the patients quality of life suffering from DIMDs. Parkinson's Disease depicts degenerative disorder of the central nervous system, affecting the motor system. By antagonizing the action of acetylcholine, biperiden helps restore the balance between dopamine and acetylcholine in the brain. This adjustment aids in alleviating the motor symptoms associated with Parkinson's Disease, although it does not reverse the disease progression or affect the non-motor symptoms. Tourette Syndrome is a type of neurological disorder that depicts repetitive, stereotyped, involuntary movements and vocalizations called tics. Its efficacy in Tourette Syndrome largely depends on the individual patient's response to the medication and the nature of their symptoms. The anticholinergic action of biperiden can help mitigate certain motor tics, but clinicians should carefully weigh its benefits against potential side effects.

Regional Insights

The Biperiden market in the Americas is characterized by a robust healthcare infrastructure, high awareness of neurological disorders, and strong regulatory support. The United States, being the largest market in the region, demonstrates significant demand due to an aging population and the prevalence of Parkinson's disease and extrapyramidal symptoms. Regulatory approvals and insurance coverage policies significantly influence the market dynamics in this region. Furthermore, Latin America shows promising growth potential, attributed to improving healthcare facilities, rising healthcare expenditures, and increasing awareness of neurological disorders. In the EMEA region, Europe stands out as a central market for biperiden, supported by its advanced healthcare systems, high spending on healthcare, and an increasing incidence of Parkinson's disease. The presence of well-established pharmaceutical companies, coupled with favorable regulatory environments, further drives the market. The Asia Pacific region shows an opportunistic landscape for the growth of the biperiden market, driven by burgeoning populations, escalating healthcare needs, and increasing prevalence of Parkinson's disease and other related disorders. Countries including China and India are pivotal due to their immense population base and rapidly evolving healthcare sectors. Increased investments in healthcare infrastructure, growing middle-class populations, and rising awareness about neurological disorders are key factors propelling the market in this region.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Biperiden Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Biperiden Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Biperiden Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AbbVie Inc., ACTYLIS, Adooq Bioscience LLC, BioCrick BioTech, Biotechne Corporation, Clearsynth, Enomark, MANUS AKTTEVA BIOPHARMA LLP, Merck KGaA, NIKSAN PHARMACEUTICAL, Rafa Laboratories Ltd., SAKHIYA PHARMA CHEM, Salvavidas Pharmaceutical Pvt. Ltd., Shreeji Pharma International, Simson Pharma, and Synnat Pharma.

Market Segmentation & Coverage

This research report categorizes the Biperiden Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Administration
  • Injection
  • Oral

• Application
  • Drug-induced Movement Disorders
  • Parkinson Disease
  • Touret Syndrome

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam

• Europe, Middle East & Africa
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Biperiden Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Biperiden Market?

3. What are the technology trends and regulatory frameworks in the Biperiden Market?

4. What is the market share of the leading vendors in the Biperiden Market?

5. Which modes and strategic moves are suitable for entering the Biperiden Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing use of biperiden to treat parkinson's disease globally
    • 5.1.1.2. Rising usage of biperiden in drug developement of drug-induced movement disorders
  • 5.1.2. Restraints
    • 5.1.2.1. Limited awareness and high cost of biperiden manufacturing
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing research and development to enhance the applicability of biperiden-based drugs
    • 5.1.3.2. Emerging investments by pharmaceutical companies in biperiden production
  • 5.1.4. Challenges
    • 5.1.4.1. Potential health affects associated with biperiden
• 5.2. Market Segmentation Analysis
  • 5.2.1. Administration: Increasing preferences for Oral administration owing to their ease of use and patient compliance
  • 5.2.2. Application: Proliferation of biperiden in drug-induced movement disorders as potent anticholinergic agent
• 5.3. Market Disruption Analysis
• 5.4. Porter's Five Forces Analysis
  • 5.4.1. Threat of New Entrants
  • 5.4.2. Threat of Substitutes
  • 5.4.3. Bargaining Power of Customers
  • 5.4.4. Bargaining Power of Suppliers
  • 5.4.5. Industry Rivalry
• 5.5. Value Chain & Critical Path Analysis
• 5.6. Pricing Analysis
• 5.7. Technology Analysis
• 5.8. Patent Analysis
• 5.9. Trade Analysis
• 5.10. Regulatory Framework Analysis

6. Biperiden Market, by Administration

• 6.1. Introduction
• 6.2. Injection
• 6.3. Oral

7. Biperiden Market, by Application

• 7.1. Introduction
• 7.2. Drug-induced Movement Disorders
• 7.3. Parkinson Disease
• 7.4. Touret Syndrome

8. Americas Biperiden Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Biperiden Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Biperiden Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
  • 11.3.1. Merck Seals USD 610 Million Biobucks Deal to Acquire Preclinical Neurodegenerative Biotech Caraway
  • 11.3.2. AbbVie Acquires Parkinson's Drug in Latest Biotech Buyout
  • 11.3.3. Serina-AgeX Merger to Develop Treatment for Advanced Parkinson's
• 11.4. Strategy Analysis & Recommendation

12. Competitive Portfolio

• 12.1. Key Company Profiles
• 12.2. Key Product Portfolio